Veterinary Neurodegenerative Disease Diagnostics Market Size Worth USD 805.79 Million by 2034 | CAGR: 8.49%

The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report “Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/veterinary-neurodegenerative-disease-diagnostics-market/request-for-sample

The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.

Top of FormVeterinary Neurodegenerative Disease Diagnostics Market Report Highlights

• In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.
• Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.
• In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.
• The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.
• The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.
• The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.
• A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.

Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:

By Product Outlook (Revenue, USD Million, 2020–2034)

• Consumables, Reagents & Kits
• Equipment & Instruments

By Test Outlook (Revenue, USD Million, 2020–2034)

• Imaging
  • MRI (Magnetic Resonance Imaging)
  • CT (Computed Tomography)
  • Others
• Biomarker Diagnostic Tests
  • CSF (Cerebrospinal Fluid) biomarkers
  • Blood-based biomarkers
  • Others
• Others

By Animal Type Outlook (Revenue, USD Million, 2020–2034)

• Livestock
  • Sheep
  • Cattle
  • Others
• Companion
  • Canine
  • Feline
  • Equine
  • Others

By Indication Outlook (Revenue, USD Million, 2020–2034)

• Cognitive Dysfunction
• Cerebellar Abiotrophy
• Spongiform Encephalopathies
• Others

By End Use Outlook (Revenue, USD Million, 2020–2034

• Veterinary Hospitals and Clinics
• Veterinary Diagnostic Laboratories
• Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America